4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-010975
Chief Business Officer sold 40,000 shares at $16.18 ($647,200)
- Chief Business Officer acquired 40,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Savill Corrine Chief Business Officer | 2024-02-01 | Option exercise 10b5-1 | +40,000 | $4.30 | $172,000 | 205,990 | D |
| Savill Corrine Chief Business Officer | 2024-02-01 | Sale 10b5-1 | −40,000 | $16.18 | $647,200 | 165,990 | D |
| Derivatives | |||||||
| Savill Corrine Chief Business Officer | 2024-02-01 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −40,000 | 70,331 | D | ||
| Open-market sales · 40,000 sh · avg $16.18 · $647,200 | |||||||
Loading xslF345X05/ownership.xml…